Clinical trial
Early Versus Delayed Pneumococcal Vaccination in HIV
NCT00137605 · CIHR Canadian HIV Trials Network, Other · Completed
Key facts
| NCT number | NCT00137605 |
|---|---|
| Title | Early Versus Delayed Pneumococcal Vaccination in HIV |
| Official title | A Pilot Study Assessing the Efficacy of Pneumococcal Vaccine in HIV Patients: Delayed Versus Immediate Immunization |
| Lead sponsor | CIHR Canadian HIV Trials Network, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | Pneumovax, Prevnar |
| Enrollment | 79 |
| Start date | Sep 1, 2004 |
| Completion | Oct 1, 2007 |
| First posted | Aug 30, 2005 |
| Last update posted | Feb 13, 2014 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: